EGFR TKIs have been reported to activate autophagy as a cytoprotective response in various cancer cell lines, including breast cancer [333], lung cancer [573,574], squamous cell carcinoma, and transitional cell carcinoma [337]. Here, EGFR is linked to breast carcinoma.